Having established the role of the GD2-SIGLECE/7-SHP2 signaling axis in suppressing macrophage-mediated phagocytosis and promoting lung metastasis in osteosarcoma, we next investigated therapeutic potential of targeting this pathway. Here, PTPN11 is linked to osteosarcoma.